Evidence map›Paper›PMID 24324159›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection.

Tobias A W Holderried, Philipp A Lang, Hye-Jung Kim, Harvey Cantor

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. CD8+ Regulatory T Cells.Annual review of immunology · 2026
    Review
  4. An angel or a devil? Current view on the role of CD8Journal of translational medicine · 2024
    Review
  5. Review
  6. The Yin and Yang of Targeting KLRG1Frontiers in immunology · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. CD8Frontiers in immunology · 2021
    Review
  11. Article
  12. Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and ChronicFrontiers in cellular and infection microbiology · 2020
    Article
  14. Functional Characterization of Ly49Frontiers in immunology · 2020
    Article
  15. Towards Clinical Translation of CD8International journal of molecular sciences · 2019
    Review
  16. Advances in the Study of CD8+ Regulatory T Cells.Critical reviews in immunology · 2019
    Review
  17. Review
  18. Review
  19. Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein.Journal of visualized experiments : JoVE · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Tobias A W HolderriedDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02215.
Philipp A Lang
Hye-Jung Kim
Harvey Cantor
Harvard University · USDana-Farber Cancer Institute · USHeinrich Heine University Düsseldorf · DE

Funding

IMMUNOLOGIC MECHANISMS THAT PREVENT AUTOIMMUNITYR01AI037562 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1996 to 2021
$9.4M
Postdoctoral Training Program in Cancer ImmunologyT32CA070083 · NCI · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1997 to 2012
$2.8M
NCI NIH HHS T32 CA070083NCI NIH HHS T32CA070083NIAID NIH HHS AI 037562NIAID NIH HHS R01 AI037562
6 · The paper itself

Abstract

The immunological interactions that regulate the T-cell response to chronic viral infection are insufficiently understood. Here we study a cellular interaction that may enhance the antiviral immune response and constrain immunopathology. We analyze the contribution of Qa-1-restricted CD8(+) regulatory T cells (Treg cells) to antiviral immunity after infection by lymphocytic choriomeningitis virus. These CD8(+) Treg cells recognize and eliminate target cells through an interaction with the murine class Ib MHC molecule Qa-1 (HLA-E in humans). Using Qa-1 mutant mice (B6.Qa-1-D227K [B6-DK]) that harbor a single mutation that abrogates binding of Qa-1 peptide to the CD8-TCR (T-cell receptor) complex, we show that disruption of immune suppression mediated by CD8(+) Treg cells results in robust antiviral immune responses in both acute and chronic viral infection. Enhanced antiviral responses of B6-DK mice were accompanied by increased control of virus, reduced tissue inflammation in the acute phase, and dramatic alleviation of disease in the chronic phase. In addition, CD8(+) effector T cells in B6-DK mice displayed a less exhausted phenotype characterized by decreased expression of programmed cell death 1 (PD-1), LAG3 (CD223), and 2B4 (CD244) and increased expression of NKG2D (CD314) and killer cell lectin-like receptor subfamily G member 1 (KLRG1). Enhanced antiviral immunity in B6-DK mice reflected, in part, reduced inhibition of CD8(+) effector cells by CD8(+) Treg cells. These findings indicate that direct inhibition of effector CD8(+) T cells by Qa-1-restricted CD8(+) Treg cells results in increased disease severity and delayed recovery. These data suggest that depletion or inactivation of CD8(+) Treg cells represents a potentially effective strategy to enhance protective immunity to chronic viral infection.

Indexed as

Adoptive TransferAnimalsCD8-Positive T-LymphocytesDNA Virus InfectionsFlow CytometryHistocompatibility Antigens Class IImmunity, CellularLymphocytic choriomeningitis virusMiceMice, Inbred C57BLMice, TransgenicMutationStatistics, NonparametricT-Lymphocytes, RegulatoryHistocompatibility Antigens Class IQ surface antigensimmune regulationkiller cell Ig-like receptorT-cell exhaustion

Identifiers

PMID24324159
PMCPMC3876206
OpenAlexW1978498621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.